DJIA 17,021.41 -9.73 -0.06%
NASDAQ 4,509.24 -9.66 -0.21%
S&P 500 1,985.67 1.54 0.08%
market minute promo

Novo Nordisk (NYSE: NVO)

47.29 -0.48 (-1.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

NVO $47.29 -1.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.51
Previous Close $47.77
Daily Range $47.28 - $47.51
52-Week Range $32.55 - $48.42
Market Cap $130.0B
P/E Ratio 0.00
Dividend (Yield) $0.61 (1.3%)
Ex-Dividend Date
Dividend Pay Date
03/21/14
04/02/14
Volume 199,944
Average Daily Volume 1,054,809
Current FY EPS $1.79

Sector

Healthcare

Industry

Drugs

Novo Nordisk (NVO) Description

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals. Website: http://www.novonordisk.com/

News & Commentary Rss Feed

2 New Diet Drugs Coming Soon?

Orexigen Therapeutics and Novo Nordisk are close to bringing new diet drugs to market. But will doctors prescribe them?

Aveva sinks; Novo Nordisk climbs: Europe’s big stock movers

New Diabetes Drugs Gain Approval - Florins Versus Oral Insulin

Novo Nordisk's Saxenda Gets Positive Opinion for Obesity - Analyst Blog

Novo Gets Positive Vote From FDA For Anti-Obesity Treatment - Still A Long Road Ahead

Sector Update: Health Care Stocks Falling; Novo Nordisk Rising After FDA Advisory Panel Gives Nod to

Sector Update: Health Care Stocks Falling; Novo Nordisk Rising After FDA Advisory Panel Gives Nod to New Obesity Drug

Sector Update: Health Care

Surprising New Competitor: Should Arena Pharmaceuticals, Inc. and Orexigen Therapeutics, Inc. Be Afr

A new weight loss pill from Orexigen will face stiff competition from Arena's Belviq and may soon have to compete against Novo Nordisk's Saxenda.

After Apple: Tech's Takeover of Healthcare Officially Begins

Ebola is spreading, new diabetes and obesity drugs, and Apple and Google move into healthcare, because this is where the money is.

Arena Pharmaceuticals - A Biotech Value Investment

See More NVO News...

NVO's Top Competitors

NVO $47.29 (-1.00%)
Current stock: NVO
JNJ $105.06 (0.32%)
Current stock: JNJ
NVS $93.90 (-0.30%)
Current stock: NVS
RHHBY $37.12 (0.43%)
Current stock: RHHBY